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Abstract
“Omics” based concepts and techniques are gaining momentum in the field 
of oral medicine, spurred on by rapid advancements within the field of precision 
diagnostics and therapeutics. Oral cancer, specifically oral squamous cell carcinoma 
is the most common head and neck cancer, posing both diagnostic and prognostic 
challenges globally. Saliva offers several advantages as a diagnostic tool and has 
gained recognition as a biological medium for liquid biopsy. Salivary biomarkers, 
such as exosomes not only contain the full spectrum of genomic, lipidomic and 
proteomic material from its cell of origin, but are also more stable and consistently 
measurable in saliva due to their phospholipid structural protection of their mer-
chandise/contents. Salivary exosomes are mediators in communication and transfer 
of contents between cancer and normal cells and thus key role players in mediat-
ing the tumor environment. Even though exosomes have been widely employed 
to investigate systemic diseases including head and neck cancers, unraveling the 
biologic mechanisms, scope of application of salivary tumor-derived exosomes and 
overcoming restrictions in this emergent field of saliva-exosomics warrants further 
investigation.
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1. Introduction
Despite the fact, that there is a relatively wider coverage and application of 
several emerging molecular and omics-based techniques, in the field of medicine; 
many of these concepts (and techniques) are only beginning to gain recognition in 
the field of dentistry [1]. The completion of the human genome project [2–4], has 
expanded the trajectory for precision diagnostic and therapeutic potential thereof 
across many biomedical fields [5, 6]. The clinical lexicon in the post-genomic era is 
now burgeoning with various personalized application of genomics (and phenom-
ics) to improving the cancer management pipelines [1, 6–9].
Orthogonal (but complementary) multimodal approaches to conventional histo-
pathology [10, 11], such as liquid biopsies technologies have emerged as useful tools 
for clinical oncology [11–13], early tumor diagnosis and biomonitoring [14–17], as 
well as therapeutic decision making and delivery [18]. Nano-scaled multivesicular 
exosomes have emerged as important components of the tumor circulome that has 
significantly improved the cancer diagnostic field [11, 14]. Furthermore, salivary 
exosomes have been applied to improve the diagnosis of various cancers [19–26], 
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including oral cancers [25, 26]. The focus of this chapter is to review the applica-
tions and prospects of salivary exosomes in oral cancer detection (Figure 1).
2. Salivary diagnostics
Human saliva is a multifunctional biological fluid, which facilitates digestion, 
swallowing, tasting, tissue lubrication and protection against infectious organisms. 
It is comprised largely of water (99%) and other biochemical substances such as 
proteins, nucleic acids, mucins, immunoglobulins, a variety of electrolytes and lipids 
[27, 28]. Whole saliva production is derived from all the salivary glands including the 
gingival crevicular fluid [29]. Saliva, which has been used for diagnostic purposes for 
over 2000 years, plays a key role in the maintenance of general and particularly oral 
health homeostasis [30]. The health of individuals has been determined by salivary 
changes such as amount produced, smell, ropiness and gustatory sensation [31, 32].
Components of the salivary glands are responsible for production, modification, 
transportation and secretion of saliva into the oral cavity (via acinar cells, various 
ductal system cells, and myoepithelial cells) [33]. The close proximity of a network 
of highly permeable blood capillaries to the saliva producing acinar cells facilitates 
the free exchange of blood-derived molecules into the acinar cells [34], which 
enter the salivary tissues either via transcellular (passive and active transport) or 
paracellular (extracellular ultrafiltration) routes [35, 36]. This transfer potentially 
influences the molecular constituency of oral fluids. Diffusion is the most common 
transport mechanism of molecules from blood into the saliva and this process is 
driven/influenced by the size and the electric charge of the molecules [37]. Active 
transport involves the transcellular transportation of blood into saliva via secre-
tory acinar cells of the salivary glands. Ultra-filtration is the major mode by which 
molecules are transported into saliva via the paracellular route, whereby small sized 
blood molecules filter into saliva through the spaces between ductal and acinar cells 
[37]. Salivary acini secrete saliva into collecting ducts, where sodium reabsorption, 
and bicarbonate and potassium are secretion takes place, thus altering the com-
position of the saliva [38, 39]. Even though blood molecules transported through 
ultra-filtration into saliva are usually in low concentration in comparison to their 
levels in blood, this mode of transport enables blood molecules such as DNA, RNA, 
proteins, metabolites and exosomes into saliva through the salivary gland. This con-
fers the possibility for oral fluids to harbor molecular information indicative of an 
individual’s current state of health. This information may be reflected by changes in 
the concentrations of these molecules or mutation in the genetic constitution of the 
Figure 1. 
Overview of origin and theranostic value of exosomes in oral cancer.
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molecules which are also present in saliva - serving as potential salivary biomarkers 
for diagnosis, prognosis and monitoring of therapeutic responses [40].
Many body fluids have been explored as alternative sources for biomarkers in 
molecular diagnosis of cancers, genetic, immunological and other systemic diseases 
[41–45]. However, blood, urine and saliva are the most used media for discovery of 
biomarkers [46]. Saliva is a rich source of proteins and its DNA, RNA, and protein 
content is analogous to that of blood with significant commonality in hormones, 
antibodies and other molecules. Most of the resident salivary protein constituents are 
synthesized within the salivary glands, with the rest transported from blood or lymph 
into saliva and used as biomarkers for disease diagnosis and screening purposes [47].
Saliva has the advantages over blood in that it is a readily available specimen 
which can be collected by non-invasive techniques and is recommended as the diag-
nostic medium in vulnerable populations such as children. The retrieval of multiple 
salivary samples from the same individual is possible with minimal discomfort and 
saliva is safer to work with when compared with blood samples. For example, there 
are some factors in saliva which help to inhibit HIV infectivity thereby limiting the 
rate of HIV transmission through the oral cavity [48]. Saliva sample processing 
is more economical and does not clot making it easier to store and ship with less 
manipulation. However, the low level of protein detection in saliva is sensitive to the 
method of saliva collection and specimen contamination. Normal high-abundance 
salivary constituents such as amylase and proline rich proteins (during stimulated 
salivary collection methods especially), may dilute the presence of low-level 
proteins, which may be more important biomarkers.
Salivary biomarkers are miniscule and measured in (picograms), detection of 
which can only be achieved by techniques which are both sensitive and specific 
enough to discriminate between them [49]. Technological advances in diagnostic 
detection methods (next generation sequencing, mass spectrometry, genome wide 
association studies and other screening techniques) have paralleled the demand for 
improved diagnostic test accuracy of salivary genomic and proteomic biomarkers, 
thereby conferring distinct advantages for saliva in the diagnosis and monitoring of 
diseases such as oral cancer and precancer.
Salivary exosomes, which are nano-sized salivary biomarkers equipped with all 
the molecular cargo from the parent cells, have become increasingly detectable due 
to their stability in the circulation and bodily fluids. They have been extensively 
explored as diagnostic tools for local and systemic diseases [50].
2.1 Salivary exosome physiology
Fusion of nano-sized (30–100 nm in diameter) multivesicular bodies (MVB) 
[51] derived from the endocytic pathway with plasma membrane was discovered 
over 30 years ago [52]. Johnstone et al., detected the release of small vesicles into 
extracellular spaces by reticulocyte MVB’s and observed that their enzymatic 
activity mirrored that of the cell culture from which they were shed [52]. These 
bodies (exosomes), originally believed to be involved in waste disposal, due to their 
resistance to degradation by lysozymes, is now more understood to subserve vital 
biological functions when released as extracellular vesicles [53]. These functions 
are influenced/determined by their target cell with which they interact and include 
cellular communication and homeostasis, immune control (they contain IgA), RNA 
processing and transport of drugs [53–55].
Exosomal release (after formation of intraluminal vesicles), can be compared to 
the reversal of the endocytosis process, permits their evaluation in the extracellular 
body fluid environments [56]. The exocytotic release of exosomes into the extracel-
lular domain, reveals that they naturally contain key molecular components derived 
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from the parent cell relating to membrane transport, lipid metabolism and extracel-
lular matrix formation [21, 57]. In addition, cytoplasmic nucleic acid contents such 
as mRNA and microRNA have been found in exosomes [21, 58, 59]. Considering the 
important contents as highlighted here, exosomes have been identified to play crucial 
roles in cell-to-cell communication [21]. All exosomes regardless of their origin possess 
both shared conserved and cell-specific proteins. Emerging knowledge has associated 
exosomes with the development of physiological and pathological perturbations [60, 
61]. For instance, cancer exosomes have been found to be capable of a range of tumor-
promoting activities, such as immunomodulation, development of pre-metastatic 
niches, as well as dysregulation of angiogenesis [62–64]. Furthermore, cancer exo-
somes are vital indicators of potentially malignant events in the tumor microenviron-
ment and may exhibit pheno-genomic perturbation biomarkers of cancer [65, 66].
2.2 Diagnostic benefits of exosomes in body fluids
Due to exosomal release into the extracellular compartment, they are abun-
dantly found in most body fluids such as cerebrospinal fluids, blood, breast milk, 
plasma, urine, serum, saliva, amniotic fluid, semen and ascetic fluid [21, 52–55]. 
Exosomes are highly suitable substrates for biomarker signature discovery. Because 
of the content-protective packaging of their rich cargo (by lipid membranes) from 
extracellular lytic enzymes, and significantly lower complexity of its contents in 
comparison to whole tissue analysis [53].
Analyzing exosomal shuttle RNA (esRNA) in maternal blood, has been pro-
posed as a potential surrogate prenatal diagnostic tool, to avoid risky invasive 
procedures such as chorionic villus sampling and amniocentesis [54]. This could 
potentially lower the risk of surgical injuries and miscarriages. Even though, cell 
free fetal DNA (cffDNA) has been previously used for the prenatal diagnostic 
purposes, the low content of fetal cffDNA has reduced the accuracy of this method 
[54, 56]. Information about cancer risk and genetic disease predisposition can be 
potentially gleaned from exosomal esRNA content analysis.
The use of novel liquid biopsy-based cancer diagnostic tools has significantly 
improved the precision and efficacy of individualized medicine, particularly in 
resource-limited settings [11]. Exosomes are capable of providing robust molecular 
tumor information about cells of origin, are retrievable from easily accessible body 
fluids; and hence are highly useful for early detection and follow-up of cancer [55].
2.3 Salivary exosomes and oral cancer
Exosomes have been successfully isolated from saliva [19–25]; and the pres-
ence of lipids, proteins and nucleic acids in exosomes, makes salivary exosomes 
attractive substrates for omics analysis (a.k.a Salivaomics) [57–60]. It has become 
emergent, that salivary constituents (e.g. mRNAs, proteins, miRNAs, microbes and 
metabolites such as lipids) may be detected in exosomes and be used as biomarkers 
for diseases (both local and distal) [54]. Structural, proteomics and transcriptomics 
analysis of salivary exosomes has been successfully carried out [61–65]; and salivary 
exosomes are fast becoming key tools in cancer biomarker theranostics. Exosomes 
have been revealed as valuable indicators of the micro-environments and perpetra-
tors of cancer intercellular communication [25].
The mean diameter and protein content are used as the basis upon which exo-
somes isolated from saliva are structurally subdivided into two types (I and II which 
are ca. 85 nm and 40 nm in diameter, respectively) [20]. Since epithelial barriers 
between blood vessels and salivary gland structures can be crossed by exosomes 
[66, 67], they have become important tools for essential transport of key signatures 
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between blood and saliva (which is believed to be an ultrafiltrate of blood) 
[67–69]. Important molecular information may be exchanged via transudation, 
ultrafiltration or selective transport based on their size or presence of transporter 
molecules [67].
Of all the head and neck cancers, oral squamous cell carcinoma is the most 
prevalent, often diagnosed in advanced stage and is associated with a low survival 
and poor prognosis. Early detection of oral cancer is a key goal in epidemiological 
cancer control and successful management thereof. Using salivary exosomes for 
identification of oral cancer biomarkers is potentially a highly sensitive, cost-
effective and non-invasive point-of-care technique for detecting oral cancer that 
may be subclinical or missed by routine histological diagnostic approaches [70]. 
Evaluation of these vesicles shed by cancer cells via multivesicular bodies (MVB’s) 
into saliva is a viable approach for biomarker detection in oral cancer (Figure 2). 
Salivary exosomes have played key roles in diagnosis of systemic diseases [51] and 
have been key player in the molecular characterization of cancer [24]. Due to its 
reduced complexity as compared to other body fluids, exosomes are reliable tools 
for early diagnosis of oral cancer and its use as a diagnostic tool may significantly 
improve cancer survival rates [24].
Due to its nano-scaled structure, human salivary exosomes have been identi-
fied as potential carriers for non-invasive delivery of cancer biomarkers [22]. For 
example, electrochemical sensing methods, such as electric field-induced release 
and measurement (EFIRM) approach, has been used to improve the field of sali-
vary liquid biopsy [23]. Not least, salivary exosomes have been used to enhance the 
detection of human papilloma virus (HPV) positive oropharyngeal cancers [26].
The critical role of tumor-derived exosome in cancer in largely due to the 
presence of tumor-specific signatures within its functional cargos, which includes 
proteins, miRNA and mRNA (Table 1).
The significant physiological interaction and overlap of the blood and salivary 
proteome (ca. 20–30%) makes exosomal protein biomarkers attractive and many 
cancer-related exosomal proteins have been identified from oral cancer [23, 82, 
83]. Potential proteomic biomarkers of oral cancer such as CFB, CD59, A1BG, M2b, 
CAT, MRP14, PFN, M2BP, ADA, S100, CFL1, IGHG, TF, IL-1B and IL-8S have been 
Figure 2. 
Pathways for escape of exosomes into saliva. Oral squamous carcinoma cells (OSCC) may release exosomes into 
saliva, either by fusion of the multivesicular body (MVB) with the plasma membrane (MF) or by plasma 
membrane rupture (MR) and direct release through endosomal membrane.
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identified from whole saliva [84–88]. However, protein biomarkers such as MUC5B, 
A2M, LGALS3BP, HPa, GAPDH, IGHA1, PIP and PKM1/M2 have been specifically 
identified to be exosomal protein biomarkers of oral cancer with a classification 
accuracy of 90% [80, 89]. Zlotogorski-Hurvitz et al. (2016), identified CD9/−81 
downregulation and CD 63 upregulation in exosomes as early diagnostic protein 
biomarkers of oral cancer [90]. Furthermore, salivary exosomes isolated from 
HPV-positive oropharyngeal cancer cell lines has been found to underexpress 
cyclin D1 and p53 and overexpress p16, T-cell inhibitory protein PTPN11 and E6/E7 
proteins [91].
Via their interaction with mRNA, micro RNA’s (miRNA) are involved in a number 
of physiological and disease processes (when there is aberrant expression). MiRNAs 
are small non-coding RNAs that mediate destabilization and/or translational repres-
sion of target messenger RNA (mRNA) molecules thereby reducing final protein 
output. Exosomes are a rich source of miRNA’s, provides a vehicle for cell to cell 
transporting to alter cellular functions as well as offer protection in the extracellular 
environment. Exosomal miRNAs have been investigated as candidate screening tools 
(miR-24-3p) [92], in chemoresistance (miR-21) [81], regulating tumor progression 
(miR-34-5p) [93] and miR-342–3p and miR-1246 [93] and miR-382-5p [78].
In oral cancer, the intercellular transfer of molecules (such as miRNA’s) by 
cancer associated fibroblast influences the tumor microenvironment. miR-21 repre-
sents one of the most abundant miRs transported within EV cargos secreted by oral 
cancer cells and is a well-established oncogenic miR whose major targets include 
the tumor suppressors. Its exosomal hideout contributes towards chemoresistance 
Biomarker Type Sample Methods References




Protein saliva Mass spectrometry analysis 
and proteomics data 
analysis
Winck et al. [71]
miRNA-21 miRNA OSCC 
cell line
miRNA sequencing Li et al. [72]
miR-1246 miRNA OSCC 
cell line
MicroRNA microarray Sakha et al. [73]





miR-34a-5p miRNA OSCC 
cell line
miRNA sequencing Li et al. [75]
PF4V1, CXCL7, F13A1, 
and ApoA1
protein serum RT-PCR Li et al. [76]
miR-101-3p miRNA OSCC 
cell line
Microarray analysis Xie et al. [77]
miR-382-5p miRNA OSCC 
cell line
RT-PCR Sun et al. [78]
miR-24-3p miRNA saliva RT-PCR He et al. [79]
miR-21-5p miRNA OSCC 
cell line
RT-PCR Chen et al. [80]
miR-155 miRNA OSCC 
cell line
RT-PCR. Kirave et al. [81]
Table 1. 
Exosome biomarker for oral cancers.
7
Diagnostic Potential of Salivary Exosomes in Oral Cancer
DOI: http://dx.doi.org/10.5772/intechopen.94192
due to the camouflage provided by its vehicle during intercellular transfer of the 
oncogenic miR. It is thus also an important chemotherapeutic precision target in 
cancers [81]. Li et al. [94], in a study of 108 patients with OSCC, observed that 
tumor exosomal miR 21 was upregulated in hypoxic cancer cells as well as internal-
ized by normoxic cells. Exosomal miR-34-5p transfer between CAF’s and neighbor-
ing OSCC cells played an important role in regulating tumor progression. Sakha et 
al. [73], demonstrated that effect that intercellular transfer of exosomal oncogenic 
miRNA’s (miR-342–3p and miR-1246) could be delivered were evaluated for their 
role in could have on cancer development and progression by influencing cell motil-
ity and invasiveness [73]. Exosomal miR-382-5p in cancer-associated fibroblast 
(CAF) mediated OSSC migration and invasion by evaluation of tissue samples from 
47 patients who had OSSC tumor resection. The results showed that CAF’s transfer 
miR-382-5p associated with migration and invasion [78]. The expression of exo-
somal miR-24-3p was found to be higher in salivary exosomes from OSCC patients 
compared to healthy controls. The AUC for miR-24-3p was 0.738 and could signifi-
cantly distinguish OSCC patients from normal individuals with 64.4% sensitivity 
and 80% specificity in 49 patients with OSSC.
The functional cargos which include mRNA has been considered as potential 
biomarker in the diagnosis and monitoring and treatment of cancer. Valadi et al. 
first described the presence of mRNAs in exosomes in 2007 [95]. Subsequently, 
studies have shown the transfer of bioactive mRNAs (tumor suppressor genes or 
oncogenes) from a malignant cell to a normal cell led to a change in the phenotype 
and malignant transformation of the normal cell [95–97].
Few studies have identified mRNA in saliva of oral cancer patients. Li et al. 
identified potential mRNA biomarker which include IL8, SAT, DUSP, IL1B, OAZ1, 
H3F3A and S100P, in saliva from oral cancer patients [98]. The study showed that 
the combination of these biomarkers was highly sensitive and specific in differenti-
ating between OSSC and healthy [98]. An in vitro study showed that oral squamous 
cell carcinoma cell line (PCI-13, UMSCC47) triggered significant increase expres-
sion level of IGFBP-3 mRNA and VEGF mRNA in recipient cells [99].
Even though exosomes have been widely employed to investigate head and neck 
squamous cell carcinomas [100–103], unraveling the biologic mechanisms and 
application of salivary tumor -derived exosomes is still an evolving science [67]. 
This emergent field of saliva-exosomics warrants further investigation.
3. Conclusions
Salivary exosomes provide viable, consistent and stable sources of cancer 
biomarkers. The scope of its utility as well as understanding the molecular mecha-
nisms which underpins it, requires further investigation. Future studies refining the 
methodology for extracellular vesicle isolation and cleansing presents the greatest 
challenge that is needed to overcome the restrictions to exploring the full scope of 
salivary exosomes in systemic diseases including oral cancer.
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